Baird Medical Investment Holdings Ltd (BDMD) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BDMD currently has 42.2M outstanding shares. with significant dilution risk as 30.5M authorized shares could dilute existing holders by 72.2%. The company has significantly diluted shareholders by 453.84% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 22, 2026 |
POS AM filing: This filing registers the issuance of up to 11,500,000 ordinary shares upon exercise of warrants and the resale of up to 34,415,562 ordinary shares by selling securityholders. |
42M | 30M |
| May 22, 2026 |
F-3 filing: Baird Medical Investment Holdings Limited filed a shelf registration statement to offer up to US$50,000,000 in aggregate of ordinary shares, preferred shares, debt securities, and warrants. |
41M | 76M |
| Apr 24, 2026 |
20-F filing | 41.0M shares outstanding |
41M | 45M |
| May 15, 2025 |
20-F filing | 29.4M shares outstanding |
29M | 45M |
| Nov 15, 2024 |
F-1 filing: This F-1 filing includes information about the issuance of ordinary shares upon the exercise of warrants and the resale of ordinary shares by selling securityholders. |
5.8M | 45M |